The potential role of nicotinamide in the secondary prevention of IDDM.
Pozzilli
P
P
Istituto II Clinica Medica, University of Rome La Sapienza, Italy.
Andreani
D
D
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D009422:Nervous System Diseases / Q000188:drug therapy; D009536:Niacinamide / Q000009:adverse effects / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy
D009536:Niacinamide